Blood clonal B‐cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation

No abstract is available for this paper.

• Publication year

  1996

• Venue

  British Journal of Haematology

• Publication date

  1996-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.1996.294826.xPMID 8562414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage.

  2009cited by this paper
• Intermittent melphalan and prednisolone therapy in plasma cell myeloma.

  2009cited by this paper
• T cells in monoclonal gammopathies.

  2009cited by this paper
• T-cell subsets in malignant lymphomas and monoclonal gammopathies.

  2009cited by this paper
• Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

  2009cited by this paper
• Bone marrow kinetic studies on three patients with myelomatosis. Indications for malignant proliferation within both the plasma cell and lymphoid cell compartments.

  2009cited by this paper
• Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma

  1994cited by this paper
• Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell

  1994cited by this paper
• The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

  1993cited by this paper
• "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.

  1993influential reference
• Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

  1992cited by this paper
• Lymphoid subsets and prognostic factors in multiple myeloma

  1992cited by this paper
• B‐cell surface phenotypes of proliferating myeloma cells: Target antigens for immunotherapy

  1990cited by this paper
• Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies.

  1990cited by this paper
• Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

  1989cited by this paper
• Circulating monotypic B‐cells in multiple myeloma: association with lambda paraproteins

  1989cited by this paper
• Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma.

  1987cited by this paper
• Blood clonal B cell excess at diagnosis in multiple myeloma: Relation to prognosis

  1987influential reference
• Detection of clonal excess in lymphoproliferative disease by kappa/lambda analysis: correlation with immunoglobulin gene DNA rearrangement.

  1986cited by this paper
• Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.

  1984cited by this paper
• Monoclonal gammopathy of undetermined significance (MGUS): a review.

  1982cited by this paper
• Idiotypic peripheral blood lymphocytes in monoclonal gammopathy.

  1982cited by this paper
• Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.

  1981cited by this paper
• Characterization of the Monoclonal Blood and Bone Marrow B Lymphocytes in Waldenström's Macroglobulinaemia

  1980cited by this paper
• Circulating lymphocytes and the spread of myeloma. Review of the evidence.

  1978cited by this paper
• IgG on Human Blood Lymphocytes Studied by Immunofluorescence

  1978cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Lymphocyte subpopulations in peripheral blood of healthy persons. Characterization by surface markers and lack of selection during purification

  1975cited by this paper
• Monoclonal lymphocyte population in human plasma cell myeloma.

  1974cited by this paper
• Design and Analysis

  1960cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Investigation and management of the monoclonal gammopathy of undetermined significance

  2023cites this paper
• Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

  2016cites this paper
• The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

  2014cites this paper
• Sjögren-szindróma és myeloma multiplex

  2012cites this paper
• Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma

  2011cites this paper
• High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.

  2010cites this paper
• Immunological and Clinical Long-Term Effects of Idiotype Vaccination in Multiple Myeloma Patients

  2007cites this paper
• B-lymphocytes as targets for therapy in chronic cold agglutinin disease.

  2007cites this paper
• Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

  2007cites this paper
• Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

  2006cites this paper
• DIFFERENTIAL DIAGNOSIS IN SJÖGREN ’ S SYNDROME : LABORATORY AND CLINICAL ASPECTS

  2006cites this paper
• Gammapathies monoclonales de signification indéterminée

  2006cites this paper
• Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.

  2005cites this paper
• Monoclonal gammopathy of undetermined significance.

  2005cites this paper
• Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.

  2004cites this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cites this paper
• Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

  2002cites this paper
• Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance

  2002cites this paper
• Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.

  2001influential citation
• Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma

  2001cites this paper
• Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

  2001cites this paper
• Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance: Cumulative Incidence and Prognostic Factors

  2001cites this paper
• Clinical Features and Outcome of Multiple Myeloma Arising from the Transformation of a Monoclonal Gammapathy of Undertermined Significance

  1999cites this paper
• Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance.

  1999cites this paper
• Recent progress in the biology of multiple myeloma and future directions in the treatment.

  1998cites this paper
• Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.

  1997cites this paper
• Paraproteinemia, plasmacytoma, myeloma and HIV infection

  1997cites this paper
• Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low‐grade malignant lymphoproliferative disease

  1997cites this paper
• Dysproportionaler Riesenwuchs, Flammennävi, Hämangiome, Varizen und Erstdiagnose einer monoklonalen Gammopathie

  1997cites this paper
• T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: Clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden

  1997cites this paper
• Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma

  1997cites this paper
• Idiotype-specific T cells in multiple myeloma:Targets for an immunotherapeutic intervention?

  1996cites this paper
• Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.

  1996cites this paper